Monitor the Biomedical Evidence that Matters to You with Custom-Tailored Intelligence

Request a Demo
Posts From the monthly archives: "April 2014"

As previously reported in this blog, review periods for biomarker-based IVD tests were shorter in 2013 for the second year in a row. This continued the reversal of a decade-long trend of increasing review periods. We can also now report that more biomarker-based tests were cleared by 510(k) in 2013 than…(Read More)